Westerweel, Peter E.

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis

The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Domingo, P., Mur, I., Mateo, G. M., Gutierrez, M. D. M., Pomar, V., de Benito, N., Corbacho, N., Herrera, S., Millan, L., et al. (2021) · JAMA

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 678

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

Mahon, F.-X., Pfirrmann, M., Dulucq, S., Hochhaus, A., Panayiotidis, P., Almeida, A., Mayer, J., Hjorth-Hansen, H., Janssen, J. J. W. M., Mustjoki, S., et al. (2024) · Journal of Clinical Oncology

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 71

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach

Ector, G. I., Westerweel, P. E., Hermens, R. P., Braspenning, K. A., Heeren, B. C., Vinck, O. M., de Jong, J. J., Janssen, J. J., & Blijlevens, N. M. (2020) · Journal of Medical Internet Research

Mobile Health and mHealth ApplicationsInnovative Human-Technology Interaction

Cited by 57

The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population‐based study in the Netherlands, 1989–2018

Maas, C. C. H. M., van Klaveren, D., Ector, G. I. C. G., Posthuma, E. F. M., Visser, O., Westerweel, P. E., Janssen, J. J. W. M., Blijlevens, N. M. A., & Dinmohamed, A. G. (2022) · British Journal of Haematology

Chronic Myeloid Leukemia TreatmentsMultiple and Secondary Primary Cancers

Cited by 31

Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population

Kockerols, C. C. B., Janssen, J. J. W. M., Blijlevens, N. M. A., Klein, S. K., Van Hussen-Daenen, L. G. M., Van Gorkom, G. G. Y., Smit, W. M., Van Balen, P., Biemond, B. J., Cruijsen, M. J., et al. (2022) · Haematologica

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 22

Prediction of sustained remission after tyrosine kinase inhibitor discontinuation with BCR::ABL1 digital PCR in chronic myeloid leukemia patients

Kockerols, C., Valk, P. J. M., Janssen, J. J. W. M., Hogenbirk, P., Cornelissen, J. J., Saussele, S., Spiess, B., Perusini, M. A., Kim, D., & Westerweel, P. E. (2024) · European Journal of Haematology

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 8